On Apr. 2, 2020, the FDAﾗin collaboration with the CDC, the Biodefense and Emerging Infections Research Resources Repository (BEI Resources), the Institute for Genome Sciences at the University of Maryland, and the National Center for Biotechnology Informationﾗdeveloped quality-controlled reference sequence data for the SARS-CoV-2 reference strain for the U.S.

Availability of traceable and quality-controlled data will help test developers and vaccine developers.